DeepKinase pioneers in proteomics for drug discovery and development, with two leading products, DoTD and DoTK.
DoTD provides mass spectrometry based quantitative proteomics to assist TPD therapeutics; results are featured in numerous IND filings.
DoTK offers patented tyrosine phosphoproteomics technology, vital to understand kinase activities and signaling in cancer and immune diseases.
DeepKinase is a global front-runner in proteomics analysis, driving novel research, biomarker discovery, and personalized medicine in pharmaceutical industry.
Site |
Badges |
|
DeepKinase Suzhou
A9 International Innovation Port, No.18 Jinxing Road, Huaqiao Economic Development Zone,Kunshan
Suzhou, JIANGSU, 215300
China
|
|
|
DeepKinase Canada
999 Collip Circle
London, Ontario, N6G 0J3
Canada
|
|
|
DeepKinase Beijing
Building 2, Court 9, Medical Park Road, Life Science Park
Beijing, Beijing, 102200
China
|
|
|
DeepKinase Beijing
Building 2, Court 9, Medical Park Road, Life Science Park
Beijing, Beijing, 102200
China
|
|
|
DeepKinase Beijing
Building 2, Court 9, Medical Park Road, Life Science Park
Beijing, Beijing, 102200
China
|
|